BD Intraosseous Infusion System— 510(k) K203193
Substantially EquivalentBard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]
FDA 510(k) clearance K203193 for BD Intraosseous Infusion System, Substantially Equivalent on 2021-03-04. Applicant: Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd].
Clearance details
- Applicant
- Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]
- Product code
- Code MHC
- Advisory panel
- General Hospital
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Salt Lake Ciy,, UT, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.